Over The Counter Testing Strategic Business Report 2024, with Profiles of 30+ Players Including i-Health Lab, LabStyle Innovations, NOWDiagnostics, OraSure Technologies, Roche Diagnostics and Sinocare

Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption and Rising Adoption of Self-Testing Kits for Chronic Disease Management


Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Over The Counter (OTC) Testing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global market for Over The Counter (OTC) Testing was estimated at US$23.3 Billion in 2023 and is projected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% from 2023 to 2030.

What Is Fueling the Growth in the OTC Testing Market?

The growth in the OTC testing market is driven by factors such as rising health awareness, the need for accessible healthcare solutions, advancements in testing technology, and the increasing prevalence of chronic conditions. As health awareness continues to rise, more people are seeking tools that allow them to monitor their health from home, leading to a greater demand for OTC tests. Consumers today are more proactive in managing their health, and OTC testing offers a convenient way to check for conditions like high blood pressure, cholesterol, and glucose levels without the need for frequent doctor visits. This self-management approach aligns with the growing trend of preventive healthcare, where individuals monitor their health regularly to detect and address potential issues early.

The need for accessible healthcare solutions has also contributed significantly to the growth of the OTC testing market, as healthcare systems worldwide face challenges in meeting the demands of an aging population and managing limited resources. OTC testing provides a cost-effective solution by enabling individuals to take routine tests at home, reducing the burden on healthcare facilities and making testing accessible to a wider population. In rural or underserved areas where healthcare access is limited, OTC testing bridges the gap by providing essential diagnostic capabilities without requiring travel to a medical facility. As healthcare costs continue to rise, OTC testing offers an affordable alternative that supports broader access to healthcare, especially in regions with limited medical infrastructure.

Technological advancements in testing accuracy and ease of use have also accelerated the adoption of OTC testing. Innovations in biotechnology have improved the reliability and specificity of OTC tests, making them highly accurate and comparable to lab-based tests. For instance, advancements in rapid diagnostic tests have made it possible to detect infectious diseases like COVID-19 and influenza at home, providing users with timely information that can guide decisions on self-isolation and medical care. Additionally, the rise of telehealth has further integrated OTC testing into healthcare, as remote consultations and digital health platforms allow patients to receive medical advice based on their at-home test results. This seamless integration of OTC testing and telemedicine is especially appealing to patients seeking accessible and efficient healthcare solutions.

Finally, the increasing prevalence of chronic conditions, such as diabetes, cardiovascular disease, and high blood pressure, has fueled demand for OTC testing products that allow for regular monitoring. As chronic diseases require frequent health checks, OTC testing offers a convenient, effective solution for patients to monitor their condition consistently. Blood glucose monitors, cholesterol tests, and blood pressure cuffs are commonly used by individuals managing these chronic conditions, enabling them to adjust their treatment plans as needed.

This trend is likely to continue as chronic conditions remain a significant public health issue, with OTC testing providing patients with the tools to manage their health proactively. Together, these factors - rising health awareness, the need for accessible healthcare, technological advancements, and the prevalence of chronic conditions - are driving substantial growth in the OTC testing market, making it a cornerstone of modern healthcare and preventive medicine.



Scope of the Study

The report analyzes the Over The Counter (OTC) Testing market, presented in terms of market value (US$ Million).

Segments

  • Test Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests, Other Test Types)
  • Technology (Lateral Flow Assays, Immunoassays, Dipsticks)

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Glucose Monitoring Tests segment, which is expected to reach US$11.7 Billion by 2030 with a CAGR of a 8.2%. The Pregnancy & Fertility Tests segment is also set to grow at 9.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $6.3 Billion in 2023, and China, forecasted to grow at an impressive 8.8% CAGR to reach $6.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Key Questions Answered:

  • How is the Global Over The Counter (OTC) Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Over The Counter (OTC) Testing Market such as Abbott Laboratories, AccuBioTech, ACON Laboratories, bioLytical Laboratories, i-Health Lab and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 33 companies featured in this Global Over The Counter (OTC) Testing Market report include:

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare


Key Attributes:

Report AttributeDetails
No. of Pages89
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$23.3 Billion
Forecasted Market Value (USD) by 2030$43.6 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal



Key Topics Covered:

MARKET OVERVIEW

  • World Market Trajectories
  • Global Economic Update
  • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

FOCUS ON SELECT PLAYERS

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

MARKET TRENDS & DRIVERS

  • Growing Demand for Home-Based Health Monitoring Drives OTC Testing Market
  • Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption
  • Rising Adoption of Self-Testing Kits for Chronic Disease Management
  • Increasing Use of OTC Testing in Monitoring Infectious Diseases Propels Demand
  • Demand for Rapid and Accurate Results Spurs OTC Testing Solutions
  • OTC Testing as a Key Solution for Reducing Healthcare Costs
  • Use in Detecting Lifestyle Disorders Expands OTC Testing Adoption
  • Rising Demand for Genetic Testing Kits Sets the Stage for Market Growth
  • Increasing Use of OTC Testing in Monitoring Diabetes and Heart Conditions
  • Increasing Focus on Female Health Solutions Expands OTC Testing Opportunities
  • OTC Testing for Allergies and Food Intolerances Generates Demand

For more information about this report visit https://www.researchandmarkets.com/r/hwjvcl

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Over The Counter (OTC) Testing Market

Kontaktdaten